NEW ROCHELLE, NY/HOUSTON, TX- Sept. 30, 2012 - The Medical Letter announces a new strategic partnership with NewCrop, LLC to incorporate The Medical Letter's objective drug information into NewCrop's leading electronic prescribing platform.
November 1, 2012 (Newswire) - "The Medical Letter content has long been recognized as quality drug information, free of industry bias. Since 1959, it has been providing physicians and other healthcare professionals with objective drug information to help them prescribe what is truly in the best interest of their patients." said Yosef Wissner-Levy, Publisher. "This partnership benefits the more than 30,000 healthcare professionals who utilize NewCrop's best-in-class e-prescribing, and EHRs that work with NewCrop."
NewCrop users now have immediate access to objective and peer-reviewed evaluations of new FDA-approved drugs, and unbiased reviews of drug classes used to treat common disorders. "NewCrop focuses on providing solutions and information to help providers and patients by providing valuable programs and information. The solutions are offered through a network of over 170 EHR partners. NewCrop is excited to add The Medical Letter to our list of offerings", said Lawrence Susnow, M.D., President and Co-Founder of NewCrop. , "The Medical Letter has, for my many years of clinical practice, been the primary source for comprehensive and objective drug information. I am pleased to be able to now present this high-quality information precisely where and when it is of most value, as drugs are being selected and prescribed."
The Medical Letter is pleased to have its content included and utilized in the field of ePrescribing. Being an integral part of EHRs allows The Medical Letter to contribute to patient safety on an even larger scale by providing valuable information at the point of care.
NewCrop, LLC provides electronic prescribing systems, delivered over the Internet and designed for incorporation into other medical applications such as EHR's. All features are available as a comprehensive user interface or, via data services, as individual components such as the new Electronic Prescribing for Controlled Substances (EPCS) module. To learn more about NewCrop, please visit www.newcroprx.com.
About The Medical Letter
The Medical Letter, Inc. is a nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of previously approved drugs in its newsletters: The Medical Letter on Drugs and Therapeutics and Treatment Guidelines from The Medical Letter. It also publishes handbooks on topics such as drugs for parasitic infections, and antimicrobial therapy. The Medical Letter, Inc., is supported entirely by subscriber fees and is based in New Rochelle, NY. For more information call (800) 211-2769 or go to medicalletter.org.
Director Marketing & Communications
The Medical Letter Inc.
145 Huguenot St., Suite 312
New Rochelle, NY 10801
Phone: 914.235.0500 Ext. 345
Vice President, Business Development
1800 Bering Dr. #600
Houston, Texas 77057